New research published in the American Journal of Clinical Nutrition sought to determine the effect of 4 amounts of DHA supplementation on the visual acuity of formula-fed infants. Other objectives were evaluated, including visual acuity maturation, red blood cell fatty acids, tolerance, anthropometric measures, and adverse events.
This double-blind randomized trial included 343 healthy, term, formula-fed infants. The infants were enrolled at 1-9 days of age and randomly assigned to be fed one of four infant formulas containing differing levels of DHA (0%, 0.32%, 0.64% and 0.96%). All other nutrients were equivalent between the formulas. Visual acuity of the infants was measured at the completion of the study at 12 months.
Infants fed control formula (0% DHA) had significantly poorer visual acuity at 12 mo of age than did infants who received any of the DHA-supplemented formulas. There were no significant differences in the visual acuity of the infants fed any of the other DHA-supplemented formulas.
DHA supplementation of infant formula at 0.32% of total fatty acids improves visual acuity. Higher amounts of DHA supplementation do not appear to provide additional improvements to visual acuity.
Birch EE, Carlson SE, Hoffman DR, Fitzgerald-Gustafson KM, Fu VLN, Drover JR, CastaƱeda YS, Minns L, Wheaton DKH, Mundy D, Marunycz J, Diersen-Schade DA. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. 2010. AJCN 91(4):848-59.
No comments:
Post a Comment